{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "0031-9302",
      "generic_name": "dextromethorphan hydrobromide",
      "labeler_name": "Haleon US Holdings LLC",
      "brand_name": "Robitussin Direct Cough",
      "active_ingredients": [
        {
          "name": "DEXTROMETHORPHAN HYDROBROMIDE",
          "strength": "15 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "0031-9302-01",
          "description": "18 CAPSULE, LIQUID FILLED in 1 BOTTLE (0031-9302-01)",
          "marketing_start_date": "20220715",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Haleon US Holdings LLC"
        ],
        "rxcui": [
          "1090487"
        ],
        "spl_set_id": [
          "70c9556b-063a-4fb3-96f6-1d4ffa495ed4"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "9D2RTI9KYH"
        ]
      },
      "marketing_category": "OTC MONOGRAPH DRUG",
      "dosage_form": "CAPSULE, LIQUID FILLED",
      "spl_id": "57d72c9c-b950-1fa9-e063-6394a90a9360",
      "product_type": "HUMAN OTC DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20220715",
      "product_id": "0031-9302_57d72c9c-b950-1fa9-e063-6394a90a9360",
      "application_number": "M012",
      "brand_name_base": "Robitussin Direct Cough",
      "pharm_class": [
        "Sigma-1 Agonist [EPC]",
        "Sigma-1 Receptor Agonists [MoA]",
        "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]",
        "Uncompetitive NMDA Receptor Antagonists [MoA]"
      ]
    }
  ]
}